Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04017871
Other study ID # EARLY_HABIT-ILE (29BRC19.0050)
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 18, 2019
Est. completion date September 17, 2021

Study information

Verified date December 2021
Source University Hospital, Brest
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

An urgent priority in the field of paediatric neurorehabilitation is the development of effective early motor interventions. Hand and Arm Bimanual Intensive Therapy Including Lower Extremities (= HABIT-ILE) applies the concepts of motor skill learning and intensive training to both the Upper Extremities (UE) and Lower Extremities (LE) and has been shown to improve aspects of motor function of the UE and LE in school age children with unilateral and bilateral Cerebral Palsy (CP) across the 3 levels of the International Classification of Functioning, Disability and Health (ICFDH). The principles and content of HABIT-ILE can be applied to pre-school children and this method is highly promising for early rehabilitation.


Description:

The primary objective of this study is to evaluate the effect of two weeks of early HABIT-ILE on gross motor function in pre-school children with unilateral and and bilateral Cerebral Paralysy (CP), in comparison with two weeks of usual motor activity including usual rehabilitation (control group).


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date September 17, 2021
Est. primary completion date September 17, 2021
Accepts healthy volunteers No
Gender All
Age group 12 Months to 59 Months
Eligibility Inclusion Criteria: - Child with unilateral cerebral palsy or Child with bilateral cerebral palsy proven spastic or dyskinetic - Aged from 1 to 4 years old (12 to 59 months) (age corrected if prematurity) able to follow instructions and to be able to carry out all the evaluations, according to his age Exclusion Criteria: - Age> 2 years old (35 months) or 4 years old (59 months) during the internship evaluation period - Uncontrolled epilepsy - History of botulinum toxin injection or surgery in the 6 months preceding the study period or scheduled within 3 months (during the study period) - Visual or cognitive impairment that may interfere with the management - Common contraindications to magnetic resonance imaging (MRI) such as metal implants

Study Design


Related Conditions & MeSH terms


Intervention

Other:
MRI
MRI at baseline and J90
Electro-Encephalography-High Density (children with unilateral PC only)
Electro-Encephalography-High Density (children with unilateral PC only) at baseline and J90
3D and EMG analysis
3D and EMG analysis at baseline and J90
care and classic activities
physiotherapy and psychomotility. As needed weekly sessions of speech therapist or orthoptist and daily activities of the child.
Device:
Accelerometers
During 5 days a sensor at each wrist to quantify their movement.

Locations

Country Name City State
France Les Capucins Angers
France Fondation ILDYS - Site de Ty Yann Brest

Sponsors (6)

Lead Sponsor Collaborator
University Hospital, Brest Fondation Paralysie Cérébrale, Université Catholique de Louvain, University Angers, University of Lausanne Hospitals, University Pisa

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assistive Hand Assesment (AHA/miniAHA) (for unilateral CP only) measures and describes how children with upper limb disability in one hand use his/her affected hand collaboratively with the non affected hand in bimanual play.The score range from 0 to 100 as a percentage. 100 is the best outcome. 1 hour
Primary Gross Motor Function Measure (GMFM) (for bilateral CP only) measures change in gross motor function over time in children with cerebral palsy. The score range from 0 to 100 as a percentage. 100 is the best outcome. 1 hour
See also
  Status Clinical Trial Phase
Recruiting NCT05317234 - Genetic Predisposition in Cerebral Palsy N/A
Recruiting NCT05576948 - Natural History of Cerebral Palsy Prospective Study
Completed NCT04119063 - Evaluating Wearable Robotic Assistance on Gait Early Phase 1
Completed NCT03264339 - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy N/A
Completed NCT05551364 - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy N/A
Completed NCT03902886 - Independent Walking Onset of Children With Cerebral Palsy
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Not yet recruiting NCT04081675 - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed NCT02167022 - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy N/A
Completed NCT04012125 - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy N/A
Enrolling by invitation NCT05619211 - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities Phase 1
Completed NCT04489498 - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed NCT03677193 - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy N/A
Recruiting NCT06450158 - Robot-assisted Training in Children With CP N/A
Completed NCT04093180 - Intensive Neurorehabilitation for Cerebral Palsy N/A
Completed NCT02909127 - The Pediatric Eating Assessment Tool
Not yet recruiting NCT06377982 - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy Phase 1
Not yet recruiting NCT06007885 - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention. N/A
Not yet recruiting NCT03183427 - Corpus Callosum Size in Patients With Pineal Cyst N/A
Active, not recruiting NCT03078621 - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy Phase 1/Phase 2